ribavirin has been researched along with deoxyguanosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robins, RK; Saunders, PP; Spindler, CD; Tan, MT | 1 |
| Jefferies, MW; King, RW; Zecher, M | 1 |
| Kakibuchi, N; Kawakami, T; Kita, K; Murakami, Y; Okita, M; Takaguchi, K; Tomioka, K | 1 |
| Adachi, Y; Fujita, N; Hasegawa, K; Horiike, S; Iwasa, M; Kaito, M; Kawanishi, S; Kobayashi, Y; Ma, N; Sugimoto, R; Tanaka, H | 1 |
| Baba, N; Ikeda, F; Iwasaki, Y; Miyake, Y; Moritou, Y; Nagano, T; Nanba, S; Nouso, K; Ohnishi, H; Seki, H; Senoh, T; Takaguchi, K; Takaki, A; Takeuchi, Y; Yamamoto, K; Yasunaka, T | 1 |
2 trial(s) available for ribavirin and deoxyguanosine
| Article | Year |
|---|---|
Effects of eicosapentaenoic acid supplementation in the treatment of chronic hepatitis C patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Alanine Transaminase; Deoxyguanosine; Dietary Supplements; Eicosapentaenoic Acid; Erythrocyte Membrane; Erythrocytes; Fatty Acids; Fatty Acids, Unsaturated; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Middle Aged; Phospholipids; Recombinant Proteins; Ribavirin | 2005 |
Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Deoxyguanosine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Iron Metabolism Disorders; Leukocytes, Mononuclear; Liver; Liver Neoplasms; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oxidative Stress; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
3 other study(ies) available for ribavirin and deoxyguanosine
| Article | Year |
|---|---|
Use of tiazofurin to enhance the metabolism and cytotoxic activities of analogues of guanine, guanosine, and deoxyguanosine.
Topics: Animals; Cell Line; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Deoxyguanosine; Female; Guanine; Guanosine; Guanosine Triphosphate; Hypoxanthine Phosphoribosyltransferase; Ovary; Ribavirin; Ribonucleosides | 1987 |
Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.
Topics: Antiviral Agents; Cell Line; Deoxyadenosines; Deoxycytidine; Deoxyguanosine; Deoxyuridine; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Genes, Reporter; HeLa Cells; Hepacivirus; Hepatocytes; Humans; Interferon-alpha; Interferon-beta; Kidney; Luciferases; Recombinant Fusion Proteins; Ribavirin; RNA, Viral; Templates, Genetic; Virus Replication | 2002 |
Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Alanine Transaminase; Antimicrobial Cationic Peptides; Antiviral Agents; Aspartate Aminotransferases; Deoxyguanosine; DNA Adducts; DNA Damage; Drug Therapy, Combination; Female; Ferritins; Hepatitis C, Chronic; Hepcidins; Humans; Interferons; Iron Overload; Liver; Male; Middle Aged; Oxidative Stress; Ribavirin | 2007 |